| HOME >> BIOLOGY >> TECHNOLOGY |
Operating expenses:
Cost of revenue 584,230 1,183,312 978,130 2,006,152
General and
administrative 659,246 1,924,816 1,577,385 3,187,882
Research and
development 269,247 916,793 595,702 1,237,215
Total operating
expenses 1,512,723 4,024,921 3,151,217 6,431,249
Operating income
(loss) (774,573) (2,529,303) (1,144,092) (3,315,871)
Other income
(expense):
Interest expense (14,954) (14,506) (29,878) (26,756)
Interest income 42,565 66,655 75,218 108,331
Other - - 179,000 -
Income (loss) before
income taxes (746,962) (2,477,154) (919,752) (3,234,296)
Provision for income
taxes - 7,269 800 8,069
Net income (loss) (746,962) (2,484,423) (920,552) (3,242,365)
Preferred stock
dividends 233,562 179,064 467,123 412,625
Net income (loss)
attributable to
common stockholders $(980,524) $(2,663,487) $(1,387,675)$ (3,654,990)
Net income (loss)
per share-basic $ (0.36) $ (0.58) $ (0.51) $ (1.00)
Net income (loss)
per share-diluted $ (0.36) $ (0.58) $ (0.51) $ (1.00)
Weighted-average
shares- basic 2,726,320 4,562,815 2,726,320 3,644,568
Weighted-average
shares-diluted 2,726,320 4,562,815 2,726,320 3,644,568
SOURCE Response Genetics, Inc.![]() Copyright©2007 PR Newswire. |